FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Neolpharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for methylphenidate hydrochloride from Neolpharma, Inc. under ANDA208737, granting approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)